To further validate the results suggesting the role of lipid metabolizing genes in anti-VEGF response, we assessed the scale of anti-VEGF injections given to AMD patients (for 11 AMD patients, Fig. 4). This evidence concerns the gene VEGFA and age-related macular degeneration.